FDA removes warning for hormone replacement therapy for menopause

The Food and Drug Administration said Monday that it will reverse two decades of precedent by removing “black box” warnings on hormone replacement therapy products for menopause, with the intent of increasing access to products to relieve common symptoms. The warnings of negative long-term health effects from such therapy will be removed…
Read More